MiR-301a mediates the effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by regulating PTEN expression

Cellular Physiology and Biochemistry

Volumn 35, Issue 4, 2015, Pages 1413-1424

  Dou, Lin ^a   Wang, Shuyue ^a,b   Sui, Xiaofang ^c   Meng, Xiangyu ^a,b   Shen, Tao ^b   Huang, Xiuqing ^b   Guo, Jun ^b   Fang, Weiwei ^b   Man, Yong ^b   Xi, Jianzhong ^a   Li, Jian ^b  

^a PEKING UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c JIAMUSI UNIVERSITY   (China)

Author keywords

AKT; GSK glycogensis; IL 6 PTEN; MiR 301a

Indexed keywords

GLYCOGEN; GLYCOGEN SYNTHASE KINASE; INTERLEUKIN 6; MICRORNA; MICRORNA 301A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; PTEN PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA BASE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIVER CELL; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; GLYCOGENOLYSIS; LIVER; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELL LINE; DOWN-REGULATION; GLYCOGEN; GLYCOGEN SYNTHASE KINASES; GLYCOGENOLYSIS; HEPATOCYTES; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 84925428451     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000373962     Document Type: Article

References (29)

1. Petersen KF, Shulman GI: New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy. Obesity 2006;14:34-40.
2. Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A: Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 2007;47:142-156.
3. Kim JH, Bachmann RA, Chen J: Interleukin-6 and insulin resistance. Vitam Horm 2009;80:613-633.
4. Sarvas JL, Khaper N, Lees SJ: The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK. J Diabetes Metab 2013. Doi. 10.4172/2155-6156.S13-003.
5. Shi H, Cave B, Inouye K, Bjorbaek C, Flier JS: Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 2006;55:699-707.
6. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA: Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003;52:2784-2789.
7. Klover PJ, Clementi AH, Mooney RA: Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 2005;146:3417-27.
8. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
9. Williams MD, Mitchell GM: MicroRNAs in insulin resistance and obesity. Exp Diabetes Res 2012;2012:484696.
10. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M: A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004;432:226-230.
11. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R: MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 2006;28:26932-26942.
12. Baroukh N, Ravier MA, Loder MK, Hill EV, Bounacer A, Scharfmann R, Rutter GA, Van Obberghen E: MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 2007;282:19575-19588.
13. Esau C, Kang X, Perala E, Hanson E, Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R, Dean NM, Freier SM, Bennett CF, Lollo B, Griffey R: MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004;279:52361-52365.
14. Karbiener M, Fischer C, Nowitsch S, Opriessnig P, Papak C, Aihaud G, Dani C, Amri EZ, Scheideler M: microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun 2009;390:247-251.
15. Martinelli R, Nardelli C, Pilone V, Buonomo T, Liguori R, Castano I, Buono P, Masone S, Persico G, Forestieri P, Pastore L, Sacchetti L: miR-519d overexpression is associated with human obesity. Obesity 2010;18:2170-2176.
16. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH, Stoffel M: MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011;474:649-653.
17. He A, Zhu L, Gupta N, Chang Y, Fang F: Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 2007;21:2785-2794.
18. Ling HY, Ou HS, Feng SD, Zhang XY, Tuo QH, Chen LX, Zhu BY, Gao ZP, Tang CK, Yin WD, Zhang L, Liao DF: CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin Exp Pharmacol Physiol 2009; 36: 32-39.
19. Dou L, Zhao T, Wang L, Huang X, Jiao J, Gao D, Zhang H, Shen T, Man Y, Wang S, Li J: miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes. J Biol Chem 2013;288:22596-22606.
20. Lee YH, Na HS, Jeong SY, Jeong SH, Park HR, Chung J: Comparison of inflammatory microRNA expression in healthy and periodontitis tissues. Biocell 2011;35:43-49.
21. Wang M, Li C, Yu B, Su L, Li J, Ju J, Yu Y, Gu Q, Zhu Z, Liu B: Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol 2013;48:1023-1033.
22. Ma F, Zhang J, Zhong L, Wang L, Liu Y, Wang Y, Peng L, Guo B: Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/beta-catenin signaling. Gene 2014;535:191-197.
23. Lu Z, Li Y, Takwi A, Li B, Zhang J, Conklin DJ, Young KH, Martin R, Li Y: miR-301a as an NF-kappaB activator in pancreatic cancer cells. EMBO J 2011;30:57-67.
24. Panguluri SK, Tur J, Chapalamadugu KC, Katnik C, Cuevas J, Tipparaju SM: MicroRNA-301a mediated regulation of Kv4.2 in diabetes: identification of key modulators. PLoS One 2013;8:60545.
25. Wu L, Zhao Q, Zhu X, Peng M, Jia C, Wu W, Zheng J, Wu XZ: A novel function of microRNA let-7d in regulation of galectin-3 expression in attention deficit hyperactivity disorder rat brain. Brain Pathol 2010;20:1042-1054.
26. Gao D, Nong S, Huang X, Lu Y, Zhao H, Lin Y, Man Y, Wang S, Yang J, Li J: The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 2010;285:29965-29973.
27. O'Neill CM, Lu C, Corbin KL, Sharma PR, Dula SB, Carter JD, Ramadan JW, Xin W, Lee JK, Nunemaker CS: Circulating levels of IL-1B+IL-6 cause ER stress and dysfunction in islets from prediabetic male mice. Endocrinology 2013;154:3077-3088.
28. Guo J, Li M, Meng X, Sui J, Dou L, Tang W, Huang X, Man Y, Wang S, Li J: MiR-291b-3p Induces Apoptosis in Liver Cell Line NCTC1469 by Reducing the Level of RNA-binding Protein HuR. Cell Physiol Biochem 2014;33:810-822.
29. Gupta A, Dey CS: PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance. Mol Biol Cell 2012;23:3882-3898.